So far, little is known about the physiological role of fatty acid transport protein 4 (Fatp4, Slc27a4). Mice with a targeted disruption of the Fatp4 gene display features of a human neonatally lethal restrictive dermopathy with a hyperproliferative hyperkeratosis, a disturbed epidermal barrier, a flat dermal-epidermal junction, a reduced number of pilo-sebaceous structures, and a compact dermis, demonstrating that Fatp4 is necessary for the formation of the epidermal barrier. Because Fatp4 is widely expressed, it is unclear whether intrinsic Fatp4 deficiency in the epidermis alone can cause changes in the epidermal structure or whether the abnormalities observed are secondary to the loss of Fatp4 in other organs. To evaluate the functional role of Fatp4 in the skin, we generated a mouse line with Fatp4 deficiency inducible in the epidermis. Mice with epidermal keratinocyte-specific Fatp4 deficiency developed a hyperproliferative hyperkeratosis with a disturbed epidermal barrier. These changes resemble the histological abnormalities in the epidermis of newborn mice with total Fatp4 deficiency. We conclude that Fatp4 in epidermal keratinocytes is essential for the maintenance of a normal epidermal structure.
Recently, we generated mice with a targeted disruption of the Fatp4 gene within intron 2 to analyze the functional significance of Fatp4 (Herrmann et al, 2003) . The Fatp4 null mice displayed features of a human neonatally lethal restrictive dermopathy (Holbrook et al, 1987; Dean et al, 1993) . Their skin was characterized by a hyperproliferative hyperkeratosis with a disturbed epidermal barrier, a flat dermalepidermal junction, a reduced number of pilo-sebaceous structures, and a compact dermis. The rigid skin consistency resulted in an altered body shape with facial dysmorphia, generalized joint flexion contractures, and impaired movement, including suckling and breathing deficiencies. The morphological alterations were accompanied by a severely compromised epidermal barrier function. Lipid analysis demonstrated a disturbed fatty acid composition of epidermal ceramides with a reduced proportion of very long chain fatty acid residues within the ceramide fraction of Fatp4-deficient epidermis. These findings revealed a previously unknown, essential function of Fatp4 in the formation of the epidermal barrier. Another mouse line carrying a naturally occurring mutation in exon 3 of the Fatp4 gene leading to Fatp4 deficiency (Moulson et al, 2003) displayed the same phenotype, confirming our findings. But another genetically engineered mouse line with a targeted disruption of the Fatp4 gene (Gimeno et al, 2003) where exons 2 and 3 were replaced by a selectable marker cassette exhibited a far more severe phenotype with early embryonic lethality before day 9.5 of gestation. The reason for the differences between the two mouse lines with disruption of the Fatp4 gene within intron 2 and exon 3, respectively, and the mouse line with disruption of the Fatp4 gene at the 5 0 side of exon 2 is unclear. Immunofluorescence microscopy localized Fatp4 to the stratum granulosum and the stratum spinosum of the epidermis (Herrmann et al, 2003) . But it remained unclear whether the lack of Fatp4 in the epidermis was the primary cause of the dominant skin phenotype of mice with generalized Fatp4 deficiency or whether the alterations in the skin architecture were secondary phenomena because of the lack of Fatp4 elsewhere. To answer this question, we used a variation of Cre/lox conditional mutagenesis based on ligand inducible recombination (Logie and Stewart, 1995; Metzger et al, 1995) . In addition to placing loxP sites strategically within the Fatp4 gene, a Cre recombinase-mutant estrogen receptor fusion protein (ER T2 ) was used to render conditional mutagenesis of Fatp4 dependent upon the administration of tamoxifen (Feil et al, 1997; Brocard et al, 1998; Metzger and Chambon, 2001) . Because Cre-ER T2 expression was directed by the K14 promoter (Li et al, 2000) , conditional mutagenesis of Fatp4 was confined to epidermal keratinocytes after tamoxifen administration. Thereby, we show that Fatp4 in the epidermis itself is essential for the maintenance of a normal epidermal structure.
Abbreviations: AFT, after the first tamoxifen treatment; X-gal, 5-bromo-4-chloro-3-indolyl-b, D-galactopyranoside Copyright r 2005 by The Society for Investigative Dermatology, Inc.
Results
Generation of Fatp4 mutant mice The strategy used for the generation of Fatp4 mutant mice with epidermis-specific Fatp4 inactivation is shown in Fig 1A. To generate mice with a floxed Fatp4 allele (Fatp4 flox/wt ), Fatp4 neoflox/wt mice were crossed with transgenic mice expressing FLPe recombinase (Rodriguez et al, 2000) . Fatp4 flox/wt mice were crossed with K14-Cre-ER T2 transgenic mice (Li et al, 2000) to generate Fatp4 flox/wt K14-Cre-ER T2(tg/0) double-mutant mice carrying a floxed Fatp4 allele and the K14-Cre-ER T2 transgene. To generate mice with an Fatp4 null allele (Fatp4
neoflox/wt mice were crossed with PGK-Cre transgenic mice (Schwenk et al, 1995 PCR analysis was used to identify the different genotypes and to detect the Cre-mediated recombination of the allele Fatp4 flox to the allele Fatp4 Dex3 (Fig 1B) .
Phenotype of Fatp4 mutant mice Mice with epidermisspecific Fatp4 deficiency (esi-Fatp4 mice) did not show any gross abnormality in comparison with control littermates neither 7 nor 13 wk after the first tamoxifen treatment (AFT). Their behavior and gross appearance were also normal. Only histological examination revealed distinct changes. The stratum corneum of esi-Fatp4 mice was considerably thicker than that of control littermates (Fig 2) . The stra-
Figure 2
Abnormalities generated in skin of adult mouse by tamoxifen-induced disruption of Fatp4 mediated by K14-Cre-ER T2 . Skin of mutant mice and control littermates 7 and 13 wk after the first tamoxifen treatment (AFT). Skin from the snout (A), eyelid (B), ear (C), back (D), and foot pad (E) was stained with hematoxylin and eosin. In comparison with control epidermis, Fatp4 mutant (esi-Fatp4) epidermis exhibited more cell layers in the stratum spinosum and the basal layer. (F) Immunohistochemical analysis using anti-Ki-67 antibodies showed an increase in the number of positive cells in the basal layer and also several positive suprabasal cells in the skin from the eyelid of esi-Fatp4 mice compared with control mice. Scale bar, 50 mm. The staining pattern using antisera against K10 shows all suprabasal cells (stratum spinosum and stratum granulosum; white bracket, ss þ sg) to be positive, with considerable widening of both layers in Fatp4 mutant mice (yellow bracket, ss þ sg). (E) Keratin K2e is expressed very late during terminal keratinocyte differentiation of the skin and is detectable only in the stratum granulosum cells of control mice (white bracket, sg), whereas in Fatp4 mutant mice it is strongly increased in both the stratum spinosum and stratum granulosum (yellow bracket, ss þ sg). Loricrin (F), filaggrin (G), and transglutaminase 1 (H) are typical proteins of the cornified envelope and specific components of the process of terminal keratinocyte differentiation. They all can be detected in the upper stratum spinosum and in the stratum granulosum of control mice (F-H, white brackets). In Fatp4 mutant mice, these proteins are regularly seen in the uppermost stratum spinosum as well as most prominently in the broadened stratum granulosum (F-H, yellow brackets). (I) The presence of claudin-1 in the cell-cell borders of all layers of the skin (white bracket, ss-sg) indicates an intact tight junction barrier in both kinds of mice, whereas in Fatp4 mutant mice the staining is restricted to the strata spinosum and granulosum (yellow bracket, ss þ sg). Blue staining: DAPI-stained nuclei. gl, sebaceous gland. Scale bar, 50 mm. tum spinosum was characterized by an increased number of cell layers. In comparison with newborn mice with generalized Fatp4 deficiency, however, the alterations were less pronounced. The flat dermal-epidermal junction, the reduced number of pilo-sebaceous structures, and the condensed dermis with compact collagen fibers present in newborn mice with generalized Fatp4 deficiency could not be observed in adult esi-Fatp4 mice, neither 7 nor 13 wk AFT. In addition, no ultrastructural differences between control and transgenic mice could be detected, including lamellar membranes as well as the number and shape of lamellar bodies (data not shown).
All other organs, including the brain, intestine, liver, spleen, kidneys, myocardium, lung, thymus, and skeletal muscle (not shown), examined by light microscopy appeared normal in esi-Fatp4 mice both 7 and 13 wk AFT.
Immunohistochemical analysis revealed an increased number of Ki-67-positive nuclei in the basal layer of esiFatp4 mouse epidermis in comparison with control mouse epidermis (7 wk AFT: 45% vs 9%; 13 wk AFT: 42% vs 19%). Whereas in control mouse skin all positive nuclei were located in the basal layer of the epidermis or in the outer root sheath or matrix of hair follicles (data not shown), in esiFatp4 mouse skin some Ki-67-positive cells were observed in the first suprabasal layer (Fig 2F) . Thus, the observed hyperkeratosis could be classified as a hyperproliferative hyperkeratosis.
The immunofluorescence studies were performed on foot sole and on snout epidermis (data not shown). For Fatp4 immunofluorescence microscopy, we used an antiserum that we generated against a specific peptide (Herrmann et al, 2003) . By using staining protocols without detergent addition in any of the fixation and incubation steps (see Materials and Methods), a decoration along the cell margins of the stratum granulosum was seen in Fatp4 neoDex3/flox K14-Cre-ER T2(0/0) mice (henceforth termed control mice; Fig 3A, white open arrow), and a very faint but nonspecific cytoplasmic staining (cf. Herrmann et al, 2003) was seen in the keratinocytes of the lower stratum basale. This specific Fatp4 staining was not detectable in tamoxifen-treated Fatp4 neoDex3/flox K14-Cre-ER T2(tg/0) mice (esiFatp4 mice; Fig 3A, yellow open arrow). Special aspects could be observed when investigating skin appendages. Besides the interfollicular epidermis, in control snout skin, Fatp4 was most prominent at the cellular margins of trichocytes of hair follicle cortex and keratinocytes of the inner root sheath and less pronounced in those of the outer root sheath (Fig 4A, B) . Furthermore, the epithelial cells of the sebaceous glands were also positive for Fatp4 (Fig 4C) . In mutant animals, as already mentioned, Fatp4 staining of the interfollicular epidermis was no longer detectable and the staining in the sebaceous glands and the outer root sheath was also lost (Fig 4D) . Remarkably, the staining of the hair follicle cortex, the inner root sheath, and the companion layer was not affected (Fig 4D, inset and E) . No specific Fatp4 staining of dermal components could be detected.
As keratin K14 is expressed neither in the hair fiber nor in the inner root sheath (Langbein et al, 1999 (Langbein et al, , 2001 (Langbein et al, , 2002b (Langbein et al, , 2003 ; for a review see Langbein and Schweizer, 2005) , the maintenance of Fatp4 staining after the tamoxifen-induced, K14 promoter-controlled inactivation of Fatp4 in these K14-negative tissue compartments is reasonable. Otherwise, in the K14-positive sebaceous glands (Hughes et al, 1996) and the outer root sheath (Coulombe et al, 1989) , Fatp4 staining was, like in the interfollicular epidermis, lost. These results can clearly be assessed as an ''internal proof'' of the specificity and efficiency of the knockout technique used in this work.
The skin of esi-Fatp4 mice was hyperplastic, hyperkeratotic, and parakeratotic. Therefore, we investigated the differentiation of keratinocytes, particularly the occurrence and distribution of specific keratins and other proteins of the cornified envelope, by using standard protocols including detergent permeabilization (see Materials and Methods). Keratin K14 (Fig 3B) was markedly restricted to the stratum basale of control skin. The skin of esi-Fatp4 mice showed a comparable immunostaining pattern but with K14 labelling extended to the first or more suprabasal layers (Fig 3B, yellow open arrow), indicative of increased cell proliferation in the Fatp4 mutant skin. This proliferative characteristic of the esi-Fatp4 epidermis was also demonstrable by the intense reaction for keratin K6 (Fig 3C) : whereas in the foot sole epidermis of control mice typically only the keratinocytes of the basal layer and few suprabasal cells within the secondary ridges were positive for K6 (Fig 3C, white bracket) , in esiFatp4 mouse cells, this keratin was labelled in the basal and also in the suprabasal layers, in the stratum spinosum, and particularly in the stratum granulosum (Fig 3C, yellow bracket) . Strong keratin K10 reactivity was observed in all living suprabasal cell layers (Fig 3D, white bracket, ss þ sg) , but appeared much broader in the hyperkeratotic foot sole of esi-Fatp4 mice (Fig 3D, yellow bracket, ss þ sg) . Neither the stratum basale nor the stratum corneum reacted in either kind of mice. The immunostaining of keratin K2e was restricted to the keratinocytes of the stratum granulosum in control mice (Fig 3E; white bracket, sg), whereas it was greatly widened, extending to the cells of the upper stratum spinosum, in esi-Fatp4 mice (Fig 3E; yellow bracket, ss þ sg) . The stage of cornification of the skin keratinocytes was investigated by the immunolocalization of loricrin (Fig 3F) , filaggrin (Fig 3G) , and transglutaminase I (Fig 3H) : all of these proteins were seen in their typical localizations in both esiFatp4 and control animals, the only consistent difference being that more cell layers showed immunoreactivity in the skin of esi-Fatp4 mice, indicative of the hyperkeratinization (Fig 3F-G, yellow brackets) .
Immunohistochemical staining of the tight junction proteins claudin-1, occludin, and protein ZO-1 virtually reproduced their typical wild-type localization (cf. Morita et al, 1999; Brandner et al, 2002; Langbein et al, 2002a) i.e. occludin exclusively in the stratum granulosum (data not shown), whereas protein ZO-1 (data not shown) and claudin-1 could also be detected at the cell margins of cells of the lower strata (Fig 3I, white bracket, sb-sg; cf. also Morita et al, 1999; Brandner et al, 2002; Langbein et al, 2002a) . In the Fatp4 mutant animals, both proteins were often detected in the additional layers of the thickened skin. Remarkably, under these conditions, claudin-1 was no longer detectable in the stratum basale of esi-Fatp4 mice (Fig 3I,  yellow bracket, ss þ sg) .
Epidermal barrier function in esi-Fatp4 mice To examine whether the observed abnormal skin structure might also be associated with an impaired skin barrier function, two different techniques were applied. The substrate 5-bromo-4-chloro-3-indolyl-b, D-galactopyranoside (X-gal) penetrated esi-Fatp4 skin, where it was cleaved to produce a colored precipitate by endogenous b-galactosidase activity, whereas the skin of control mice was impermeable (Fig 4F) . In another set of experiments it was shown that the fluorescent dye Lucifer yellow permeated throughout the entire epidermis in esi-Fatp4 mice; in contrast, it did not pass through the upper layers of the stratum corneum in control mice (Fig 4G) . Thus, we concluded that the abnormal epidermal structure of esi-Fatp4 mice was accompanied by a compromised epidermal barrier function.
Discussion
Mice with generalized Fatp4 deficiency exhibit a characteristic phenotype with distinct abnormalities in the structure and a disturbed barrier function of the epidermis (Herrmann et al, 2003; Moulson et al, 2003) . How Fatp4 deficiency leads to these severe alterations is still unclear. As Fatp4 acts as an acyl-CoA synthetase for long and very long chain fatty acids (Herrmann et al, 2001; Hall et al, 2005) and Fatp4À/À mice exhibit a disturbed fatty acid composition of epidermal ceramides (Herrmann et al, 2003) , Fatp4 might play an important role in the epidermal ceramide metabolism.
The mutation within the Fatp4 gene of our mouse line and the Fatp4-deficient mouse line described by Moulson et al (2003) is located within intron 2 and exon 3, respectively. Because we generated a gene trap vector to target the Fatp4 gene with a mutant multipurpose Fatp4 allele, we had to integrate the cassette with the selectable marker after the first coding exon, i.e., after exon 2. Another mouse line with a disruption of the Fatp4 gene at the 5 0 side of exon 2 exhibits a far more severe phenotype with early embryonic lethality before gestational day 9.5 (Gimeno et al, 2003) . The reason for this difference is still elusive. It has been speculated that the disruption of intron 2 or exon 3, respectively, might give rise to a trunkated form of Fatp4 with a rest activity leading to a less severe phenotype than observed when the Fatp4 gene is disrupted within exon 1. This truncated protein, however, would carry only the first 53 amino acids of Fatp4, whereas the length of the total deduced Fatp4 amino acid sequence is 643 amino acids.
Fatp4 is widely expressed in many organs. Its physiological function in these organs has so far remained elusive. The gene is also strongly expressed in the skin, as we have shown at the RNA level by Northern blot analysis (Herrmann et al, 2001 ) and quantitative RT-PCR (not shown), as well as at the protein level by immunofluorescence (Herrmann et al, 2003) . But proof has not been provided that the lack of Fatp4 in the epidermis causes the phenotype of Fatp4-deficient mice. It might be conceivable that the lack of Fatp4 in another tissue or other tissues causes secondary effects on the generation and maintenance of the epidermal structure. To find out whether Fatp4 indeed plays a pivotal role in the (D, E) ). Note that the inner root sheath and the hair cortex remain positive for Fatp4 in esi-Fatp4 mice. Remarkably, the hair follicle companion layer also remains Fatp4 positive (triangle in E). (F) Access of 5-bromo-4-chloro-3-indolyl-b, D-galactopyranoside (X-gal) to ear skin. Control epidermis is impermeable to X-gal. In contrast, X-gal permeates Fatp4 mutant skin, where it is cleaved by endogenous bgalactosidase activity to produce a colored precipitate. (G) Diffusion of Lucifer yellow in ear skin. The fluorescent dye Lucifer yellow does not pass the upper layers of the stratum corneum in control mice. In contrast, in Fatp4 mutant mice it permeates the entire epidermis. Scale bar, 50 mm (A-E, G).
epidermis for the maintenance of a normal skin structure, the generation of a mouse line with keratinocyte-specific Fatp4 deficiency (Li et al, 2000; Metzger and Chambon, 2001 ) appears to be a promising approach.
In this paper, we describe the generation of the first conditional Fatp4-deficient mouse line at all. This mouse line displays distinct changes in the structure of the epidermis and a compromised epidermal barrier function resembling the changes in mice with generalized Fatp4 deficiency. Thus, we show that the function of Fatp4 in keratinocytes is essential for the maintenance of a normal epidermal structure.
Certain features of newborn mice with generalized Fatp4 deficiency could not be observed in our mice with epidermis-specific Fatp4 deficiency, like the flat dermalepidermal junction, the reduced number of pilo-sebaceous structures, and the condensed dermis with compact collagen fibers. Whereas newborn mice with total Fatp4 deficiency can be recognized at first sight because of their characteristic appearance, esi-Fatp4 mice are not distinguishable from their control littermates macroscopically. Possible explanations for the milder phenotype of adult esiFatp4 mice in comparison with newborn mice with total Fatp4 deficiency are: (1) as described (Li et al, 2000) , we treated mice at the age of 10 wk with tamoxifen for 5 consecutive days, and again for 5 consecutive days, 2, 4, and 6 wk later, and examined them 7 and 13 wk AFT, respectively. Possibly, this period of time might not be sufficient for the development of all alterations observed in newborn mice with generalized Fatp4 deficiency, and further changes in the skin architecture might become visible after a longer period of observation or a longer time course of tamoxifen treatment. (2) The recombination efficiency of K14-Cre-ER T2 might be below 100%. A small rest activity of Fatp4 in the epidermis of esi-Fatp mice might lead to a milder phenotype than in mice with total Fatp4 deficiency; however, we could not detect Fatp4 protein by immunofluorescence 7 or 13 wk AFT. Furthermore, Li et al (2000) already described a complete recombination of a floxed RXRa allele by K14-Cre-ER T2 . (3) Fatp4 might be more important for the generation than for the maintenance of the epidermal barrier.
The epidermis of mice with generalized Fatp4 deficiency exhibits an abnormal lipid composition, the most striking difference being an increase of the ceramide fraction by about 80% and a decrease of very long chain fatty acids with at least 26 C atoms within the ceramide fraction from 64% to 26% in Fatp4-deficient mice (Herrmann et al, 2003) . Although an analysis of the lipid composition of the epidermis of esi-Fatp4 mice has not been performed, we assume that the mechanisms that lead to these very similar phenotypes are identical because of the identical underlying genetic cause. Of note, in addition to their structural role in the epidermis, ceramides are also involved in various signalling pathways that control differentiation and proliferation (Huwiler et al, 2000) .
The availability of a mouse model with inducible epidermis-specific Fatp4 deficiency in the skin will enable further projects for analysis of the details of Fatp4 function in the skin of adult mice. By means of this mouse line, it will be possible to determine the sequence of morphological events that lead to the observed hyperkeratosis, to characterize the metabolic changes in Fatp4-deficient epidermis further, and to detect delayed consequences of the observed morphological and functional changes.
Materials and Methods
Genotyping of Fatp4 alleles Genomic DNA was isolated from tissues by standard techniques. The epidermis was separated from the dermis after heating tail skin in distilled water to 641C for 10 s. Fatp4 genotyping was performed by PCR with primer pairs specific for the wt, the flox, the neoDex3, and the Dex3 alleles, respectively.
Generation of Fatp4 mutant mice The generation of Fatp4 mutant mice has been reported previously (Herrmann et al, 2003) . The original mouse line carried the mutant allele Fatp4 neoflox (Fatp4-K; Herrmann et al, 2003) harboring a gene trap cassette in intron 2 (Fig 1A) . By crossing this mouse line with a transgenic mouse line expressing FLPe recombinase (Rodriguez et al, 2000) , the gene trap cassette was excised, and the mutant allele Fatp4 neoflox was converted into the mutant allele Fatp4 flox , which carried two loxP sites within introns 2 and 3, respectively (Fig 1A) . Mice homozygous for the ''floxed'' Fatp4 allele showed no phenotypic abnormalities, indicating that the allele Fatp4 flox was functionally fully active. When mice carrying the Fatp4 flox allele were crossed with PGK-Cre transgenic mice (kindly provided by Klas Kullander and Ruediger Klein) exhibiting ubiquitous Cre expression (Schwenk et al, 1995) , the Fatp4 flox allele was converted into the null allele Fatp4
Dex3 (Fig 1A) . Offspring homozygous for the Fatp4 Dex3 or Fatp4 neoflox alleles were analyzed for morphological differences and were found to be identical (data not shown). All procedures were in compliance with the guidelines of the institutional animal care and use committees, and in accordance with governmental guidelines. Institutional approval was granted for all experiments.
To generate mice with tamoxifen-inducible Fatp4 inactivation in the epidermis, mice carrying the Fatp4 flox allele were crossed with transgenic mice carrying the K14-Cre-ER T2 transgene that expresses the tamoxifen-inducible Cre-ER T2 recombinase specifically in keratinocytes (Li et al, 2000) . The resulting mice used for the experiments had a mixed genetic background C57BL/6-129SV/Ola.
Tamoxifen treatment As described (Li et al, 2000) , tamoxifen (Sigma, St. Louis, Missouri; 0.1 mg in 100 mL sunflower oil) was injected intraperitoneally into female mice at the age of 10 wk for 5 consecutive days, and again for 5 consecutive days, 2, 4, and 6 wk later. Animals were sacrificed 7 or 13 wk AFT, and tissues were analyzed by histology, immunohistochemistry, and electron microscopy.
Histological analysis Histological analysis of the heart, lung, liver, spleen, kidney, stomach, duodenum, jejunum, ileum, colon, skeletal muscle, adipose tissue, and skin from dorsal and ventral trunk, ears, eyelids, snout, feet, and tail from control and tamoxifentreated (7 wk AFT and 13 wk AFT) mice was performed as described previously (Herrmann et al, 2003) .
Antibodies The primary antibodies used in immunohistochemistry were as follows: (1) guinea-pig antibodies against mouse Fatp4 (1:500; Herrmann et al, 2003) , K14 (1:3000), K2e (1:2000) (both from Progen Biotechnik, Heidelberg, Germany), (2) mouse antibodies against transglutaminase 1 (1:20, CellSystems, St. Katharinen, Germany), (3) rabbit antibodies against keratin K10 (1:500, Covance, Denver, Pennsylvania), filaggrin (1:500, Covance), claudin-1 (1:100, Neomarkers Labvision, Fremont, California), loricrin (1:500, Covance), periplakin (1:500, a gift from Dr D. Hohl, Baylor College, Houston, Texas), and keratin K6 (1:500, Covance), (4) rat antibodies against DAKO, Glostrup, Denmark) .
The secondary antibodies used for indirect immunofluorescence were goat antibodies to guinea-pig, rabbit, mouse, or rat immunoglobulins, coupled to Alexa 568 (dilution of 1:200; Molecular Probes, Eugene, Oregon).
Immunofluorescence microscopy and electron microscopy Indirect immunofluorescence microscopy procedures for membrane-associated proteins and cytoskeletal components were essentially performed as described in Herrmann et al (2003) (see also Schmidt et al, 1997; Langbein et al, 2002a) . All investigations were performed in parallel on foot sole and snout skin of mice 7 and 13 wk AFT. In brief, the standard protocol was applied by using cryostat sections of freshly frozen tissues, fixed in acetone (5 min at À201C), permeabilized with 0.1% Triton X-100/PBS for 2 min, followed by blocking with 5% normal goat serum in PBS. Primary and secondary antibodies were applied for ca. 45 min. For Fatp4 protein demonstration, various fixative protocols were used to prevent loss of soluble proteins (see protocols 2 and 3; Schmidt et al, 1997) . The tissues were fixed with formaldehyde and antibodies applied for 45 min, or for a shorter time without using any detergents. Negative control immunostaining reactions were performed using non-immunized serum instead of the primary antibodies at the respective dilution or only the secondary antibody against immunoglobulins of the respective species. All of them were found to be negative. Moreover, ''internal controls'' exist by using the panel of different antibodies of several species indicated in the paragraph ''Antibodies.'' DAPI for nuclear counterstaining was added to the secondary antibodies. Visualization and documentation were done by using a photomicroscope (Axiophot II, Carl Zeiss, Germany).
Electron microscopical investigations on the skin of esi-Fapt4 and control mice 7 and 13 wk AFT were conducted as described in Herrmann et al (2003) .
Skin permeability assays The diffusion of 1 mM Lucifer yellow in Ringer's solution (pH 7.4) at 371C was analyzed as described (Matsuki et al, 1998) . The frozen ear skin samples of animals 7 and 13 wk AFT, respectively, were sliced at a thickness of 5 mm and the sections were analyzed by fluorescence microscopy.
In addition, barrier-dependent access of X-gal to untreated skin was examined as described (Hardman et al, 1998) .
